Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Uterine Cervical Dysplasia × Electrocoagulation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Papillomavirus Infections 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Sexually Transmitted Diseases 1 Ovarian Cysts 1 Neoplasms 1 Menorrhagia 1 Lung Neoplasms 1 Leiomyoma 1 High-grade Anal Intraepithelial Neoplasia 1 HIV Infections 1 Endometriosis 1 Condylomata Acuminata 1 Benign Ovarian Tumor 1 Acquired Immunodeficiency Syndrome 1

Interventions

Colposcopy 14 Imiquimod 11 Conization 10 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 7 Cryotherapy 7 Papillomavirus Vaccines 6 Biopsy 6 Vaginal Smears 5 human papillomavirus vaccine, L1 type 16, 18 4 Human Papillomavirus DNA Tests 4 Acetic Acid 4 Watchful Waiting 3 Vaccines 3 VGX-3100 2 Spectrometry, Fluorescence 2 Restraint, Physical 2 Polymerase Chain Reaction 2 Mass Screening 2 Indomethacin 2 Human Papillomavirus Recombinant Vaccine nonavalent 2 High-Throughput Screening Assays 2 GX-188 vaccine 2 Fluorouracil 2 Flow Cytometry 2 Cyclophosphamide 2 Curcumin 2 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2 poly(gamma-glutamic acid) 1 pembrolizumab 1 nimotuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02956239 2024-07-08

DELTA

International Agency for Research on Cancer

Phase NA Completed

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡